News
Icade signs agreement to sell stake in Italian healthcare assets to BNPP REIM for c. €173m. Deal to close in Q4 2025, advancing strategic plan ...
Boron One Holdings Inc. announces non-brokered private placement of up to $500,000. Units priced at $0.04 with warrants. Proceeds for working capital. Subject to approvals ...
Oxurion NV received transparency notifications from UBS Group AG regarding share holdings, in compliance with Belgian Transparency legislation. The company is a biopharmaceutical group focusing on the ...
Network-1 Technologies, Inc. announces Q2 2025 financial results, including no revenue for Q2, $150,000 revenue for six months, patent litigation against Samsung, and share repurchase program extensio ...
Viemed Healthcare, Inc. reports Q2 2025 financial results with net revenues reaching $63.1 million and net income increasing by 115.1% to $3.2 million. The company's operational highlights and updated ...
BGSF, Inc. reports $23.5M revenues in Q2 2025 with a 12.6% increase from Q1, driven by higher billed hours. Gross profit rose to $8.4M while net loss was $4.9M. Adjusted EBITDA1 loss was $1.1M ...
ODIOT SA announces initiation of coverage by AlphaValue with Buy recommendation, €55.2 target price, highlighting company's rebirth as ultra-luxury maison, strong revenue growth, improved EBITDA ...
Group secures large-scale WLAN project with leading European food retailer for Europe-wide expansion. Project includes VPN routing, DNS filtering, and geolocation optimization ...
Avec Les Echos suivez en temps réel toute l'actualité financière puisée aux meilleures sources des sociétés cotées.
Swedish Electromagnet Invest AB (publ) confirms completion of divestment to PHINIA and early redemption of bond loan ...
Elis déclare les achats d'actions propres réalisés du 4 août au 8 août 2025 conformément au programme de rachat autorisé par l'assemblée des actionnaires ...
Oxurion NV (Euronext Brussel: OXUR) ontvangt transparantiekennisgevingen van UBS Group AG over aandelentransacties conform Belgische wetgeving. Oxurion, biofarmaceutisch bedrijf in Leuven, België, int ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results